Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Cortical spreading depolarizations in stroke, Mechanisms, neuroprotective interventions, and monitoring techniques

  • Díaz Pérez, Andrea|||0009-0008-2215-6344
  • Alvarez de Eulate, Nerea|||0009-0009-9031-3388
  • Masvidal Codina, Eduard|||0000-0002-9579-8603
  • Illa, Xavi|||0000-0002-3212-1128
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Guimerà Brunet, Anton|||0000-0003-1768-3293
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
  • Penas Pérez, Clara|||0000-0003-0554-3832
Cortical spreading depolarization (CSD) is a pathophysiological event critically implicated in ischemic stroke and other brain disorders. It consists of slowly propagating waves of massive neuronal and glial depolarization in cerebral gray matter, accompanied by spreading depression of cortical activity. CSD disrupts ion homeostasis, alters cerebral blood flow, and contributes to neuronal death in vulnerable tissue. This comprehensive review summarizes both classic and recent studies on CSD mechanisms and their role in brain damage progression after stroke. We also review potential neuroprotective strategies to mitigate CSD-induced damage and discuss available technologies for detecting CSD. Advancing our understanding of CSD mechanisms, combined with targeted neuroprotective strategies and improved monitoring techniques, holds promise for reducing stroke-related brain injury and guiding personalized recovery approaches.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Brain state identification and neuromodulation to promote recovery of consciousness

  • Van Der Lande, Glenn J. M.
  • Casas-Torremocha, Diana
  • Manasanch, Arnau
  • Dalla Porta, Leonardo
  • Gosseries, Olivia
  • Alnagger, Naji
  • Barra, Alice
  • Mejias, Jorge F.
  • Panda, Rajanikant
  • Riefolo, Fabio
  • Thibaut, Aurore
  • Bonhomme, Vincent
  • Thirion, Bertrand
  • Clasca, Francisco
  • Gorostiza, Pau
  • Sanchez-Vives, Maria V.
  • Deco, Gustavo
  • Laureys, Steven
  • Zamora-López, Gorka
  • Annen, Jitka
Experimental and clinical studies of consciousness identify brain states (i.e. quasi-stable functional cerebral organization) in a non-systematic manner and largely independent of the research into brain state modulation. In this narrative review, we synthesize advances in the identification of brain states associated with consciousness in animal models and physiological (sleep), pharmacological (anaesthesia) and pathological (disorders of consciousness) states of altered consciousness in humans. We show that in reduced consciousness the frequencies in which the brain operates are slowed down and that the pattern of functional communication is sparser, less efficient, and less complex. The results also highlight damaged resting-state networks, in particular the default mode network, decreased connectivity in long-range connections and especially in the thalamocortical loops. Next, we show that therapeutic approaches to treat disorders of consciousness, through pharmacology (e.g. amantadine, zolpidem), and (non-) invasive brain stimulation (e.g. transcranial direct current stimulation, deep brain stimulation) have shown partial effectiveness in promoting consciousness recovery. Although some features of conscious brain states may improve in response to neuromodulation, targeting often remains non-specific and does not always lead to (behavioural) improvements. The fields of brain state identification and neuromodulation of brain states in relation to consciousness are showing fascinating developments that, when integrated, might propel the development of new and better-targeted techniques for disorders of consciousness. We here propose a therapeutic framework for the identification and modulation of brain states to facilitate the interaction between the two fields. We propose that brain states should be identified in a predictive setting, followed by theoretical and empirical testing (i.e. in animal models, under anaesthesia and in patients with a disorder of consciousness) of neuromodulation techniques to promote consciousness in line with such predictions. This framework further helps to identify where challenges and opportunities lay for the maturation of brain state research in the context of states of consciousness. It will become apparent that one angle of opportunity is provided through the addition of computational modelling. Finally, it aids in recognizing possibilities and obstacles for the clinical translation of these diagnostic techniques and neuromodulation treatment options across both the multimodal and multi-species approaches outlined throughout the review., NA is research fellow, OG and AT are Research Associates, and SL is the research director at Fonds de la Recherche Scientifique (FRS-FNRS). JA is a postdoctoral fellow at the Fonds voor Wetenschappelijk Onderzoek (FWO) (1265522N). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the FNRS PDR project (T.0134.21), the ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), the fund Generet, the King Baudouin Foundation, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PROgramme de Développement d'Expériences scientifiques (PRODEX Programme), the Public Utility Foundation `Université Européenne du Travail', `Fondazione Europea di Ricerca Biomedica', the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the DOCMA project (EU-H2020-MSCA-RISE-778234), the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research (FERB Onlus). EU grants ICT-36-2020-101016787 (DEEPER), EIC Pathfinder GAP-101130883 (PHOTOTHERAPORT), and -EIC-2023-PATHFINDEROPEN-101130650 (META-BRAIN), Government of Catalonia AGAUR [Centres de Recerca de Catalunya (CERCA) Programme, 2021-SGR-01410; AGAUR 2021-SGR-01165 - NEUROVIRTUAL], Ministerio de Ciencia e Innovación (MICINN) grants PID2019-111493RB-I00 (DEEP RED) and PID2022- 142609OB-I00 (EPILLUM), PID2020-112947RB-I00 financed by Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 (CORTICOMOD), and Fundaluce and 'la Caixa' foundations (ID 100010434, agreement LCF/PR/HR19/52160010).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cortical spreading depolarizations in stroke: Mechanisms, neuroprotective interventions, and monitoring techniques

  • Díaz-Pérez, Andrea
  • de Eulate, Nerea Alvarez
  • Masvidal Codina, Eduard
  • Illa, Xavi
  • Navarro, Xavier
  • Guimerà-Brunet, Anton
  • Jiménez-Altayó, Francesc
  • Penas, Clara
Cortical spreading depolarization (CSD) is a pathophysiological event critically implicated in ischemic stroke and other brain disorders. It consists of slowly propagating waves of massive neuronal and glial depolarization in cerebral gray matter, accompanied by spreading depression of cortical activity. CSD disrupts ion homeostasis, alters cerebral blood flow, and contributes to neuronal death in vulnerable tissue. This comprehensive review summarizes both classic and recent studies on CSD mechanisms and their role in brain damage progression after stroke. We also review potential neuroprotective strategies to mitigate CSD-induced damage and discuss available technologies for detecting CSD. Advancing our understanding of CSD mechanisms, combined with targeted neuroprotective strategies and improved monitoring techniques, holds promise for reducing stroke-related brain injury and guiding personalized recovery approaches., Open Access Funding provided by Universitat Autonoma de Barcelona. This work was supported by grant PID2021-126117NA-I00, CNS2023-144492, PID2022-140655OB-I00, PID2020–113634RB-C22, and PDC2023-145866-I00 funded by MCIU/AEI/https://doi. org/10.13039/501100011033and by the European Union NextGenerationEU/PRTR; by the European Union’s Horizon Europe research and innovation programme under grant agreement 101130650 (META-BRAIN) and 101136541 (GphT-BCI); through the Collaborative CIBERNED-CIBERBBN 2023 project GROKE and CIBERNED (CB06/05/1105) and CIBER-BBN (CB06/01/0049) funds from Instituto de Salud Carlos III of Spain, co-funded by European Union NextGenerationEU/PRTR; and funds from 2021-SGR-00495, 2021-SGR-004488, and 2021-SGR-00969 from Generalitat de Catalunya. The IMB-CNM (CSIC) is supported by the María de Maetzu Centres of Excellence programme ref. CEX2023-001397-M funded by MCINN-AEI., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

An artefact-resilient wide bandwidth bidirectional graphene neural interface

  • Prokop, Michał
  • Esparza-Iaizzo, Martín
  • Masvidal Codina, Eduard
  • Illa, Xavi
  • Codadu, Neela K.
  • Rathore, Daman
  • Ria, Nicola
  • Kostarelos, Kostas
  • Del Corro, Elena
  • Garcia Cortadella, Ramon
  • Wykes, Rob C.
  • Guimerà-Brunet, Anton
  • Garrido, Jose A.
The ability to simultaneously record and modulate neural activity is critical for next-generation bidirectional neural interfaces aiming to enable adaptive neuromodulation therapies for neurological disorders. Active graphene transistor technologies are particularly promising for neural recordings, as they extend the ability to monitor brain activity at very low frequencies and support multiplexed operation for high-density neural interfaces. However, their limited charge injection capacity makes them unsuitable for stimulation. In this work, we present a bidirectional neural interface that combines nanoporous reduced graphene oxide (rGO) microelectrodes for high charge-injection focal stimulation and graphene solution-gated field-effect transistors (gSGFETs) for brain activity monitoring. Using scalable cleanroom microfabrication techniques, we monolithically integrate these two graphene-based technologies into fully flexible neural probes, leveraging their complementary functionalities within a single-device platform. We evaluate the performance of the hybrid devices both in saline and in vivo, with a particular focus on transistor performance during stimulation. Our results demonstrate that the recording capability of this bidirectional neural interface, including the monitoring of infraslow and local field potential activity, is not compromised during stimulation, opening avenues for future development of adaptive infraslow-based neuromodulation therapies., This research was funded by the European Union’s Horizon 2020 research and innovation program under grant agreement no. 881603 (Graphene Flagship Core 3) and the European Union’s Horizon Europe research and innovation program under grant agreement 101070865 (MINIGRAPH) and 101130650 (META-BRAIN). The ICN2 has been supported by the Severo Ochoa Centers of Excellence program [SEV-2017-0706]. ICN2 and IMB-CNM are currently supported by the Severo Ochoa Centers of Excellence and Maria de Maeztu Units of Excellence program, grant CEX2021-001214-S and grant CEX2023- 001397-M, respectively, both funded by MCIN and MCIU/AEI/10.13039.501100011033. ICN2 is also supported by the CERCA Program of Generalitat de Catalunya. This research is also funded by the Spanish Ministerio de Ciencia e Innovación (PID2020−113663RB-I00 and PID2021-126117NA-I00) founded by MCIU/AEI/10.13039/ 501100011033) and by “ERDF A way of making Europe”, PLEC2022-009232, PCI2021-122095-2A and CNS2023-144492, funded by MCIU/AEI /10.13039/501100011033 and the European Union Next-GenerationEU/PRTR. N. R. acknowledges grant PRE2020-093708 founded by MCIN/AEI /10.13039/501100011033 and by FSE. E. M. C. acknowledges grant FJC2021-046601-I funded by Agencia Estatal de Investigacion of Spain and the European Union Next-GenerationEU/PRTR. This work has made use of the Spanish ICTS Network MICRONANOFABS, partially supported by MICINN and the ICTS NANBIOSIS, specifically by the Micro-NanoTechnology Unit U8 of the CIBER-BBN. This research was supported by CIBER -Consorcio Centro de Investigación Biomédica en Red- (CB06/01/0049), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. The project that gave rise to these results received the support of a fellowship from the “la Caixa” Foundation (ID 100010434). M. P. acknowledges grant with fellowship code LCF/BQ/DI21/11860021., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (SEV-2017-0706), With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001214-S), With funding from the Spanish government through the "María de Maeztu Unit of Excellence" accreditation (CEX2023-001397-M), Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Brain state identification and neuromodulation to promote recovery of consciousness

  • Van Der Lande, Glenn J. M.
  • Casas-Torremocha, Diana
  • Manasanch, Arnau
  • Dalla Porta, Leonardo
  • Gosseries, Olivia
  • Alnagger, Naji
  • Barra, Alice
  • Mejias, Jorge F.
  • Panda, Rajanikant
  • Riefolo, Fabio
  • Thibaut, Aurore
  • Bonhomme, Vincent
  • Thirion, Bertrand
  • Clasca, Francisco
  • Gorostiza, Pau
  • Sanchez-Vives, Maria V.
  • Deco, Gustavo
  • Laureys, Steven
  • Zamora-López, Gorka
  • Annen, Jitka
Experimental and clinical studies of consciousness identify brain states (i.e. quasi-stable functional cerebral organization) in a non-systematic manner and largely independent of the research into brain state modulation. In this narrative review, we synthesize advances in the identification of brain states associated with consciousness in animal models and physiological (sleep), pharmacological (anaesthesia) and pathological (disorders of consciousness) states of altered consciousness in humans. We show that in reduced consciousness the frequencies in which the brain operates are slowed down and that the pattern of functional communication is sparser, less efficient, and less complex. The results also highlight damaged resting-state networks, in particular the default mode network, decreased connectivity in long-range connections and especially in the thalamocortical loops. Next, we show that therapeutic approaches to treat disorders of consciousness, through pharmacology (e.g. amantadine, zolpidem), and (non-) invasive brain stimulation (e.g. transcranial direct current stimulation, deep brain stimulation) have shown partial effectiveness in promoting consciousness recovery. Although some features of conscious brain states may improve in response to neuromodulation, targeting often remains non-specific and does not always lead to (behavioural) improvements. The fields of brain state identification and neuromodulation of brain states in relation to consciousness are showing fascinating developments that, when integrated, might propel the development of new and better-targeted techniques for disorders of consciousness. We here propose a therapeutic framework for the identification and modulation of brain states to facilitate the interaction between the two fields. We propose that brain states should be identified in a predictive setting, followed by theoretical and empirical testing (i.e. in animal models, under anaesthesia and in patients with a disorder of consciousness) of neuromodulation techniques to promote consciousness in line with such predictions. This framework further helps to identify where challenges and opportunities lay for the maturation of brain state research in the context of states of consciousness. It will become apparent that one angle of opportunity is provided through the addition of computational modelling. Finally, it aids in recognizing possibilities and obstacles for the clinical translation of these diagnostic techniques and neuromodulation treatment options across both the multimodal and multi-species approaches outlined throughout the review., NA is research fellow, OG and AT are Research Associates, and SL is the research director at Fonds de la Recherche Scientifique (FRS-FNRS). JA is a postdoctoral fellow at the Fonds voor Wetenschappelijk Onderzoek (FWO) (1265522N). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the FNRS PDR project (T.0134.21), the ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), the fund Generet, the King Baudouin Foundation, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PROgramme de Développement d'Expériences scientifiques (PRODEX Programme), the Public Utility Foundation `Université Européenne du Travail', `Fondazione Europea di Ricerca Biomedica', the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the DOCMA project (EU-H2020-MSCA-RISE-778234), the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research (FERB Onlus). EU grants ICT-36-2020-101016787 (DEEPER), EIC Pathfinder GAP-101130883 (PHOTOTHERAPORT), and -EIC-2023-PATHFINDEROPEN-101130650 (META-BRAIN), Government of Catalonia AGAUR [Centres de Recerca de Catalunya (CERCA) Programme, 2021-SGR-01410; AGAUR 2021-SGR-01165 - NEUROVIRTUAL], Ministerio de Ciencia e Innovación (MICINN) grants PID2019-111493RB-I00 (DEEP RED) and PID2022- 142609OB-I00 (EPILLUM), PID2020-112947RB-I00 financed by Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 (CORTICOMOD), and Fundaluce and 'la Caixa' foundations (ID 100010434, agreement LCF/PR/HR19/52160010).